Earnings Feed
Start Free
Home/Filings/4/0001140361-14-002175
4//SEC Filing

REXAHN PHARMACEUTICALS, INC. 4

Accession 0001140361-14-002175

$IRDCIK 0001228627operating
View on SEC.govCompany Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 7:26 PM ET

Size

10.3 KB

Accession

0001140361-14-002175

Insider Transaction Report

Form 4
Period: 2014-01-12
REXAHN PHARMACEUTICALS, INC.RNN
Soni Rakesh
Chief Business Officer
Transactions
  • Award

    Stock Option (right to purchase)

    2014-01-12+85,000→ 85,000 total
    Exercise: $1.14Exp: 2024-01-12→ Common Stock (85,000 underlying)
Holdings

  • Stock Option (right to purchase)

    Exercise: $0.31Exp: 2023-03-01→ Common Stock (50,000 underlying)
    50,000

  • Stock Option (right to purchase)

    Exercise: $1.29Exp: 2018-09-30→ Common Stock (300,000 underlying)
    300,000

  • Common Stock

    2,700

  • Stock Option (right to purchase)

    Exercise: $0.78Exp: 2018-12-11→ Common Stock (250,000 underlying)
    250,000
Footnotes (4)
  • [F1]Options will vest and be exercisable based on the following schedule: 25,500 on January 12, 2015, 25,500 on January 12, 2016, and 34,000 on January 12, 2017.
  • [F2]Options will vest and be exercisable based on the following schedule: 15,000 on March 1, 2014, 15,000 on March 1, 2015, and 20,000 on March 1, 2016.
  • [F3]Options vested and became exercisable based on the following schedule 75,000 on December 11, 2009, 75,000 on December 11, 2010, and 100,000 on December 11, 2011.
  • [F4]Options vested and became exercisable based on the following schedule 90,000 on September 30, 2009, 90,000 on September 30, 2010, and 120,000 on September 30, 2011.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001228627

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 7:26 PM ET
Size
10.3 KB
View on SEC.gov